October 24, 2014 4:40 AM ET

Capital Markets

Company Overview of Remeditex Ventures, LLC

Executive Profile

Dennis Stone M.D.

Chief Scientific Officer and Director, Remeditex Ventures, LLC
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Dennis Stone, M.D. serves as the Chief Scientific Officer of Remeditex Ventures, LLC. Dr. Stone served as the Head of Technology Development at UT-Southwestern Medical Center in Dallas. He served as the Vice President of Technology Development since 1998. In that role, he directed licensing operations as well as the biotechnology development initiative taking place at UTSW and was the liaison with pharmaceutical and biotechnology companies interested in partnership ...

Corporate Headquarters

2101 Cedar Springs
Dallas, Texas 75201

United States

Phone: 214-506-2662
Fax: --

Board Members Memberships

Director
Director

Education

Bachelor's Degree
The University of Texas, Austin
Unknown/Other Education
University of Texas Southwestern Medical Center - Dallas

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Remeditex Ventures, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.